Erythropoietin and neuroprotection;Érythropoïétine et neuroprotection

Archives de Pediatrie

Volumn 17, Issue SUPPL. 3, 2010, Pages

  Chatagner, A ^a   Huppi P S ^a   Ha Vinh Leuchter, R ^a   Sizonenko, S ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; NEUROPROTECTIVE AGENT;

ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; CELL HYPOXIA; CYTOKINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; HUMAN; INJURY SEVERITY; KNOCKOUT MOUSE; LONG TERM CARE; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PREMATURITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; BRAIN; GENE INACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PHYSIOLOGY; REVIEW;

BRAIN; ERYTHROPOIETIN; GENE KNOCKOUT TECHNIQUES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, ERYTHROPOIETIN;

EID: 77955891293     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(10)70905-2     Document Type: Article

References (53)

1. Quelle F.W., Wang D., Nosaka T. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic responses. Mol Cell Biol 1996, 16:1622-1631.
2. Zhao W., Kitidis C., Fleming M.D., et al. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signalling pathway. Blood 2006, 107:907-915.
3. Anagnostou A., Liu Z., Steiner M., et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994, 91:3974-3978.
4. Anagnostou A., Lee E.S., Kessimian N., et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990, 87:5978-5982.
5. Yu X., Shacka J.J., Eells J.B. Erythropoietin receptor signalling is required for normal brain development. Development 2002, 129:505-516.
6. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-KappaB signalling caspases. Nature 2001, 412:641-647.
7. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002, 106:2973-2979.
8. Juul S.E., Anderson D.K., Li Y., et al. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 1998, 43:40-49.
9. Bernaudin M., Bellail A., Marti H.H., et al. Neurons and astrocytes express EPO mRNA oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000, 30:271-278.
10. Kumral A., Ozer E., Yilmaz O., et al. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2003, 83:224-228.
11. Matsushita H., Johnston M.V., Lange M.S., et al. Protective effect of erythropoietin in neonatal hypoxic ischemic mice. Neuroreport 2003, 14:1757-1761.
12. McClure mm., Threlkeld S.W., Fitch R.H. The effects of erythropoietin on auditory processing following neonatal hypoxic-ischemic injury brain. Brain Res 2006, 1087:190-195.
13. Spandou E., Papoutsopoulou S., Soubasi V., et al. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res 2004, 1021:167-172.
14. Sun Y., Calvert J.W., Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005, 36:1672-1678.
15. Wang X., Zhu C., Wang X., et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 2004, 91:900-910.
16. Chang Y.S., Mu D., Wendland M., et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005, 58:106-111.
17. Sola A., Rogido M., Lee B., et al. Erythropoietin after focal cerebral ischemia activates the Janus kinase - signal transducer and activator of transcription signalling pathway and improves brain injury in postnatal day-7 rats. Pediatr Res 2005, 57:481-487.
18. Wei L., Han B.H., Li Y., et al. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 2006, 317:109-116.
19. Keller M., Yang J., Griesmaier E., et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 2006, 24:357-366.
20. Demers E.J., McPherson R.J., Juul S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 2005, 58:297-301.
21. Kumral A., Uysal N., Tugyan K., et al. Erythropoietin improves longterm spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 2004, 153:77-86.
22. Spandou E., Papoutsopoulou S., Soubasi V., et al. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 2005, 1045:22-30.
23. Wen T.C., Rogido M., Genetta T., et al. Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 2004, 355:165-168.
24. Brines ml, Ghezzi P., Keenan S., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97:10526-10531.
25. Kumral A., Gonenc S., Acikgoz O., et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxydation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2005, 87:15-18.
26. Juul S.E., McPherson R.J., Farrel F.X., et al. Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate 2004, 85:138-144.
27. Juul S.E., Aylwars E., Richards T., et al. Prenatal cord clamping in newborn macaca nemestrina: a model of perinatal asphyxia. Dev Neurosci 2007, 29:311-320.
28. Statler P.A., McPherson R.J., Bauer L.A., et al. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 2007, 61:671-675.
29. Sizonenko S.V., Kiss J.Z., Inder T., et al. Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr Res 2005, 57:865-872.
30. Sizonenko S.V., Sirimanne E., Mayall Y., et al. Selective cortical alteration after hypoxic-ischemic injury in the very immature rat brain. Pediatr Res 2003, 54:263-269.
31. Solaroglu I., Solaroglu A., Kaptanoglu E., et al. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 2003, 19:19-22.
32. Kumral A., Baskin H., Gokmen N., et al. Selective inhibition of nitric oxyde in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin?. Biol Neonate 2004, 85:51-54.
33. Ribatti D., Presta M., Vacca A., et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999, 93:2627-2636.
34. Shingo T., Sorokan S.T., Shimazaki T., et al. Erythropoietin regulates the in vitro production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001, 21:9733-9743.
35. Masuda S., Nagao M., Takahata K., et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993, 268:11208-11216.
36. Gorio A., Gokmen N., Erbayraktar S., et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002, 99:9450-9455.
37. Cattaneo E., Conti L., De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 1999, 22:365-369.
38. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglial, Akt1, Bad and caspase-mediate pathways. Br J Pharmacol 2003, 138:1107-1118.
39. Wang L., Zhang Z., Wang Y., et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35:1732-1737.
40. Iwai M., Cao G., Yin W., et al. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 2007, 38:2795-2803.
41. 2- isoprostanes. Am Neurol 2005, 58:108-120.
42. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001, 7:56-64.
43. Pang Y., Cai Z., Rhodes P.G. Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia. J Neurosci Res 2000, 62:510-520.
44. Sugawa M., Sukarai Y., Ishikawa-Ieda Y., et al. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 2002, 44:391-403.
45. Arishima Y., Setoguchi T., Yamaura I., et al. Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats. Spine 2006, 31:2432-2438.
46. Vitellaro-Zuccarello L., Mazzetti S., Madaschi L., et al. Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 2007, 144:865-877.
47. Bierer R., Peceny M.C., Hartenberger C.H., et al. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006, 118:e635-e640.
48. Ohls R.K., Ehrenkranz R.A., Das A., et al. Neurodevelopmental outcome and growth at 18 to 22 months'corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004, 114:1287-1291.
49. Brown M.S., Baron A.E., France E.K., et al. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS 2006, 10:143-149.
50. Bierer R., Roohi M., Peceny C., et al. Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery. J Pediatr Surg 2009, 44:1540-1545.
51. Zhu C., Kang W., Xu F., et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009, 124:e218-e226.
52. Juul S.E., McPherson R.J., Bauer L.A., et al. A phase I/II trial of highdose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008, 122:383-391.
53. Fauchere J.C., Dame C., Vonthein R., et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008, 122:375-382.